Improving the data to strengthen the global response to HIV among people who inject drugs

References 

1. Ball AL, Rana S, Dehne KL. HIV prevention among injecting drug users: Responses in developing and transitional countries. Public Health Reports. 1998;113(1):12
2. Cook C, Kanaef N. Global state of harm reduction 2008: Mapping the response to drug related HIV and hepatitis C epidemics. London: International Harm Reduction Association; 2008;
3. Day C, Degenhardt L, Gilmour S, Hall W. Effects of reduction in heroin supply on injecting drug use: Analysis of data from needle and syringe programmes. British Medical Journal. 2004;329(7463):428–429
4. Dolan K, Kite B, Black E, Aceijas C, Stimson G. HIV in prison in low-income and middle-income countries. The Lancet Infectious Diseases. 2007;7(1):32–41
   • Abstract
   • Full Text
   • Full-Text PDF (121 KB)
   • CrossRef
5. Donoghoe MC, Verster A, Pervilhac C, Williams P. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): Towards consensus and improved guidance. International Journal of Drug Policy. 2008;19S:S5–S14
6. European Monitoring Centre for Drugs and Drug Addiction . Annual report 2008: The state of the drug problem in Europe. Lisbon: EMCDDA; 2008;
7. Hickman M, Taylor C, Chatterjee A, Degenhardt L, Frischer M, Hay G, et al. Estimating the prevalence of problematic drug use: A review of methods and their application. United Nations Bulletin on Narcotics. 2002;LIV(1 & 2):15–32
8. Inciardi J, Surratt H, Pechansky F, Kessler F, von Diemen L, da Silva E, et al. Changing patterns of cocaine use and HIV risks in the south of Brazil. Journal of Psychoactive Drugs. 2006;38(3):305
   • MEDLINE
   • CrossRef
9. Kroll, C., & de Lay, P. (2009). Letter from UNODC and UNAIDS Secretariat. http://www.idpc.net/alerts/unaids-unodc-joint-letter-harm-reduction.
10. Kulsudjarit K. Drug problem in southeast and southwest Asia. Annals of the New York Academy of Sciences. 2004;1025(1 Current Status of Drug Dependence/Abuse Studies Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity):446–457
    • MEDLINE
    • CrossRef
11. Kumar, S. (2006). Injecting of pharmaceutical drugs in the SAARC region: A review. Chennai.
12. Masur H, Michelis M, Greene J, Onorato I, Stouwe R, Holzman R, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunction. New England Journal of Medicine. 1981;305:1431–1438
13. Mathers, B., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R.P., et al. (in preparation). HIV prevention, treatment and care for people who inject drugs: A systematic review of global, regional and country level coverage.
14. Mathers B, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee S, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet. 2008;372:1733–1745
15. Tilson H, Aramrattana A, Bozzette S. Preventing HIV infection among injecting drug users in high-risk countries: An assessment of the evidence. Washington, DC: Institute of Medicine; 2007;
16. World Health Organization , United Nations Office on Drugs Crime , Joint United Nations Programme on HIV/AIDS . Technical guide for countries to set targets for Universal Access to HIV prevention, treatment and care for injecting drug users. Geneva: WHO, UNODC and UNAIDS; 2009;